Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
The optimal approach after neoadjuvant treatment: The Lucerne toolbox
Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal
The optimal approach after neoadjuvant treatment: The Lucerne toolbox ( Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal )
3 Feb 2022
Neoadjuvant pembro + chemo vs placebo + chemo, followed by adjuvant pembro vs pl...
Prof Peter Schmid - Queen Mary University of London, London, United Kingdom
Neoadjuvant pembro + chemo vs placebo + chemo, followed by adjuvant pembro vs placebo for early-stage TNBC ( Prof Peter Schmid - Queen Mary University of London, London, United Kingdom )
27 Jan 2022
OncoAlert Colloquium Day 3: Breast cancer
Dr Erika Hamilton, Dr Bhawna Sirohi, Ms Ginny Mason RN, Dr Hope Rugo, Dr Sara To...
OncoAlert Colloquium Day 3: Breast cancer ( Dr Erika Hamilton, Dr Bhawna Sirohi, Ms Ginny Mason RN, Dr Hope Rugo, Dr Sara Tolaney, Dr Matteo Lambertini & Dr Icro Meattini )
19 Jan 2022
SERD vs investigator’s choice of endocrine monotherapy for ER+/HER2-advanced/mBC
Dr Aditya Bardia - Mass General Cancer Center, Boston, USA
SERD vs investigator’s choice of endocrine monotherapy for ER+/HER2-advanced/mBC ( Dr Aditya Bardia - Mass General Cancer Center, Boston, USA )
22 Dec 2021
Trastuzumab deruxtecan shows benefit across HER2+ metastatic breast cancer subgr...
Dr Sara Hurvitz - University of California, Los Angeles, USA
Trastuzumab deruxtecan shows benefit across HER2+ metastatic breast cancer subgroups ( Dr Sara Hurvitz - University of California, Los Angeles, USA )
21 Dec 2021
Neratinib + fulvestrant + trastuzumab for HR+ HER2-mutant mBC and neratinib + tr...
Dr Komal Jhaveri - Memorial Sloan-Kettering Cancer Center, New York, USA
Neratinib + fulvestrant + trastuzumab for HR+ HER2-mutant mBC and neratinib + trastuzumab for triple-negative disease ( Dr Komal Jhaveri - Memorial Sloan-Kettering Cancer Center, New York, USA )
21 Dec 2021
The RxPONDER trial and its impact on best clinical practice
Prof Christos Markopoulos and Prof Giuseppe Curigliano
The RxPONDER trial and its impact on best clinical practice ( Prof Christos Markopoulos and Prof Giuseppe Curigliano )
17 Dec 2021
OncoAlert and ecancer round up: SABCS 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer round up: SABCS 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
16 Dec 2021
Clinical utility of molecular tumour profiling in breast cancer
Prof Fabrice André - Gustave Roussy, Paris, France
Clinical utility of molecular tumour profiling in breast cancer ( Prof Fabrice André - Gustave Roussy, Paris, France )
13 Dec 2021
OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
8 Dec 2021
The Lancet Commission on women and cancer
Prof Richard Sullivan - Kings College London, London, UK & Prof Ophira Ginsburg ...
The Lancet Commission on women and cancer ( Prof Richard Sullivan - Kings College London, London, UK & Prof Ophira Ginsburg - International Agency for Research on Cancer, New York, USA )
3 Dec 2021
Breast cancer treatment and ABC global alliance communication skills training wo...
Dr Fatima Cardoso - Champalimaud Clinical Center in Lisbon, Portugal
Breast cancer treatment and ABC global alliance communication skills training workshop ( Dr Fatima Cardoso - Champalimaud Clinical Center in Lisbon, Portugal )
15 Nov 2021